Items where authors include "Coombes, RC"

Article

Cheang, MCU, Bliss, JM, Viale, G et al. (12 more authors) (2018) Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES. Breast Cancer Research and Treatment, 168 (1). pp. 169-178. ISSN 0167-6806

Asselain, B, Barlow, W, Bartlett, J et al. (107 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2018) Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 167 (1). p. 407. ISSN 0167-6806

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806

Morden, JP, Alvarez, I, Bertelli, G et al. (18 more authors) (2017) Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology, 35 (22). pp. 2507-2514. ISSN 0732-183X

Speirs, V, Viale, G, Mousa, K et al. (14 more authors) (2015) Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES) - first results from PathIES. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. ISSN 0923-7534